Belvedere Trading LLC Immuno Gen, Inc. Call Options Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	BUY	$12.46 - $29.95 $48,594 - $116,805	3,900 Added 33.33%	15,600 $462,000
Q3 2023 Oct 27, 2023	SELL	$14.09 - $19.87 $156,399 - $220,557	-11,100 Reduced 48.68%	11,700 $185,000
Q2 2023 Aug 08, 2023	SELL	$3.75 - $20.05 $62,250 - $332,830	-16,600 Reduced 42.13%	22,800 $430,000
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $144,598 - $193,848	39,400 New	39,400 $151,000
Q2 2022 Jul 21, 2022	BUY	$3.15 - $5.76 $77,175 - $141,120	24,500 New	24,500 $125,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.